---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-006678"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2022-01-24T23:59:59+00:00"
generated_at: "2026-06-27T16:17:53.168883+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals signs manufacturing agreement with Thermo Fisher's Patheon for Stendra

## Summary
- Metuchen (Petros subsidiary) and Patheon (Thermo Fisher) will collaborate on tech transfer and validation to manufacture Stendra at Patheon's Cincinnati facility.
- Agreement covers pharmaceutical development and technology transfer services to establish and validate Patheon's ability to supply Stendra.
- Commercial sale of product produced during the agreement requires a subsequent commercial manufacturing services agreement.
- After successful validation, parties will execute a commercial manufacturing agreement for release of commercially saleable products.
- Agreement effective until services completed; each party may terminate under customary conditions.

## SEC filing metadata
- accession: 0001104659-22-006678
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2022-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465922006678/0001104659-22-006678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465922006678/tm224219d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-006678
- JSON: https://secwatch.observer/filing/0001104659-22-006678.json
- Plain text: https://secwatch.observer/filing/0001104659-22-006678.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.